Kory J. Engelke

600 total citations
16 papers, 476 citations indexed

About

Kory J. Engelke is a scholar working on Molecular Biology, Surgery and Gastroenterology. According to data from OpenAlex, Kory J. Engelke has authored 16 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 3 papers in Gastroenterology. Recurrent topics in Kory J. Engelke's work include Gastrointestinal motility and disorders (3 papers), Epigenetics and DNA Methylation (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Kory J. Engelke is often cited by papers focused on Gastrointestinal motility and disorders (3 papers), Epigenetics and DNA Methylation (3 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). Kory J. Engelke collaborates with scholars based in United States and Netherlands. Kory J. Engelke's co-authors include Ryuji Ueno, Prashant K. Nighot, Anthony T. Blikslager, Adam J. Moeser, Pramod Terse, Kenneth K. Chan, Joseph M. Covey, Yonghua Ling, Yogen Saunthararajah and Jason L. Yovandich and has published in prestigious journals such as Blood, Biochemistry and Clinical Cancer Research.

In The Last Decade

Kory J. Engelke

16 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kory J. Engelke United States 10 202 106 93 85 68 16 476
Maria Niniraki Greece 9 86 0.4× 127 1.2× 52 0.6× 59 0.7× 28 0.4× 12 335
Daniele Sorcini Italy 10 366 1.8× 173 1.6× 188 2.0× 171 2.0× 94 1.4× 20 738
Giuseppe Monaco Italy 9 206 1.0× 83 0.8× 69 0.7× 48 0.6× 40 0.6× 22 398
Erin Stevens United States 6 95 0.5× 72 0.7× 285 3.1× 32 0.4× 40 0.6× 7 475
Emancipator Sn United States 9 82 0.4× 61 0.6× 153 1.6× 30 0.4× 49 0.7× 10 421
E. Sato Japan 12 101 0.5× 31 0.3× 183 2.0× 169 2.0× 35 0.5× 17 508
Qin Guo China 8 276 1.4× 15 0.1× 87 0.9× 105 1.2× 51 0.8× 23 492
Patrick S. Gentile United States 13 109 0.5× 105 1.0× 119 1.3× 123 1.4× 47 0.7× 25 455
Noria Harir Algeria 10 178 0.9× 88 0.8× 174 1.9× 164 1.9× 39 0.6× 37 514
Nobuki Maki Japan 13 236 1.2× 64 0.6× 189 2.0× 44 0.5× 21 0.3× 29 742

Countries citing papers authored by Kory J. Engelke

Since Specialization
Citations

This map shows the geographic impact of Kory J. Engelke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kory J. Engelke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kory J. Engelke more than expected).

Fields of papers citing papers by Kory J. Engelke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kory J. Engelke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kory J. Engelke. The network helps show where Kory J. Engelke may publish in the future.

Co-authorship network of co-authors of Kory J. Engelke

This figure shows the co-authorship network connecting the top 25 collaborators of Kory J. Engelke. A scholar is included among the top collaborators of Kory J. Engelke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kory J. Engelke. Kory J. Engelke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gelder, Teun van, Edgar V. Lerma, Kory J. Engelke, & Robert B. Huizinga. (2022). Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. Expert Review of Clinical Pharmacology. 15(5). 515–529. 36 indexed citations
2.
Banks, William A., Pericles Calias, Kim M. Hansen, Kristin M. Bullock, & Kory J. Engelke. (2022). Brain uptake and distribution patterns of 2-hydroxypropyl-ß-cyclodextrin after intrathecal and intranasal administration. Journal of Pharmacy and Pharmacology. 74(8). 1152–1159. 3 indexed citations
3.
Banks, William A., Kory J. Engelke, Kim M. Hansen, Kristin M. Bullock, & Pericles Calias. (2019). Modest Blood-Brain Barrier Permeability of the Cyclodextrin Kleptose: Modification by Efflux and Luminal Surface Binding. Journal of Pharmacology and Experimental Therapeutics. 371(1). 121–129. 9 indexed citations
4.
Muzzio, Miguel, Julianne L. Holleran, Robert A. Parise, et al.. (2015). Plasma pharmacokinetics of the indenoisoquinoline topoisomerase I inhibitor, NSC 743400, in rats and dogs. Cancer Chemotherapy and Pharmacology. 75(5). 1015–1023. 2 indexed citations
5.
Terse, Pramod, Kory J. Engelke, Kenneth K. Chan, et al.. (2014). Subchronic Oral Toxicity Study of Decitabine in Combination With Tetrahydrouridine in CD-1 Mice. International Journal of Toxicology. 33(2). 75–85. 10 indexed citations
6.
Mahfouz, Reda Z., Ania Jankowska, Quteba Ebrahem, et al.. (2013). Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy. Clinical Cancer Research. 19(4). 938–948. 105 indexed citations
7.
Lavelle, Donald, Kestis Vaitkus, Yonghua Ling, et al.. (2011). Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood. 119(5). 1240–1247. 72 indexed citations
8.
Sneller, Michael C., William C. Kopp, Kory J. Engelke, et al.. (2011). IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood. Blood. 118(26). 6845–6848. 81 indexed citations
9.
Moeser, Adam J., Prashant K. Nighot, Kory J. Engelke, Ryuji Ueno, & Anthony T. Blikslager. (2006). Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(2). G647–G656. 92 indexed citations
10.
Crawford, David, George Perentesis, Kory J. Engelke, & Ryuji Ueno. (2005). Effects of Lubiprostone, a Novel GI Chloride Channel Activator, on Reproductive and Developmental Toxicity Endpoints in Rats. The American Journal of Gastroenterology. 100. S331–S332. 4 indexed citations
11.
Perentesis, George, David Crawford, Kory J. Engelke, Ryuji Ueno, & Y. Kawai. (2005). In Vivo Metabolism of Lubiprostone, a Novel GI Chloride Channel Activator, in Mouse, Rat, Dog, and Monkey. The American Journal of Gastroenterology. 100. S331–S331. 3 indexed citations
12.
Crawford, David, George Perentesis, Kory J. Engelke, Y. Kawai, & Ryuji Ueno. (2005). Pharmacokinetic Profile of Lubiprostone, a Selective GI Chloride Channel Activator, after a Single Oral Dose in Multiple Animal Species. The American Journal of Gastroenterology. 100. S330–S330. 3 indexed citations
13.
Perentesis, George, et al.. (2005). Effects of Lubiprostone, a Novel GI Chloride Channel Activator, on Isolated Smooth Muscle. The American Journal of Gastroenterology. 100. S330–S330. 12 indexed citations
14.
Gan, Yuebo, Kory J. Engelke, Christopher Brown, & Jessie L.‐S. Au. (2001). Telomere Amount and Length Assay. Pharmaceutical Research. 18(12). 1655–1659. 26 indexed citations
15.
Procyk, Roman, et al.. (1992). Nonclottable fibrin obtained from partially reduced fibrinogen: characterization and tissue plasminogen activator stimulation. Biochemistry. 31(8). 2273–2278. 17 indexed citations
16.
Engelke, Kory J.. (1957). [A case of dermatochalasis].. PubMed. 12(9). 272–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Niniraki Breakdown of academic impact, for papers by Daniele Sorcini Breakdown of academic impact, for papers by Giuseppe Monaco Breakdown of academic impact, for papers by Erin Stevens Breakdown of academic impact, for papers by Emancipator Sn Breakdown of academic impact, for papers by E. Sato Breakdown of academic impact, for papers by Qin Guo Breakdown of academic impact, for papers by Patrick S. Gentile Breakdown of academic impact, for papers by Noria Harir Breakdown of academic impact, for papers by Nobuki Maki
Rankless by CCL
2026